Showing results (511-520 of 561) with videos related to
Sort By:
Pageof 57
European Journal of Cancer (Oxford, England : 1990)|September 23, 2021
Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junctionMatthieu Faron, Armel Maurice Cheugoua-Zanetsie, Pierre Thirion, et al.Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.Cancer Discovery|November 6, 2012
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradationAnna Sukhanova, Andrey Gorin, Ilya G Serebriiskii, et al.Blood Advances|November 15, 2023
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experienceRohan Shotton, Rachel Broadbent, Alia Alchawaf, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.European Journal of Cancer (Oxford, England : 1990)|April 10, 2024
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trialsAlessandra Raimondi, Young Woo Kim, Won Ki Kang, et al.Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.American Journal of Hematology|March 4, 2021
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphomaMatthew J Maurer, Lasse H Jakobsen, Raphael Mwangi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.Nature Cancer|December 24, 2021
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studyAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.Pageof 57